Novartis

The Key to Fighting Chronic Disease in South-East Asia: Young People

More than half the ASEAN region’s 630 million people are under age 30. Harald Nusser, Head of Novartis Social Business, says that to fight the rise of chronic disease in South East Asia we need to inform its youth on the importance of healthy lifestyles.
Article

How Smart Partnerships Can Help Us Fight Chronic Diseases in Africa

As WEF Africa gets underway, Harald Nusser, Head of Novartis Social Business, emphasizes how novel solutions between the public and the private sector are needed to effectively fight the rising epidemic of chronic diseases in Africa
Blog

We all agree we need partnerships between the public and the private sector to meet the Sustainable Development Goals. Public-private partnerships (PPPs) require a better understanding between partners and innovation around institutional structures to ensure accountability, risk and benefit sharing, and value for money. These are fine words but, as the representative of a large, research-based multinational, I have found that things are not always that simple... 

Partnering to Counter the Threat of Drug-resistant Malaria

On World Malaria Day, new partnerships show what’s possible; by David Reddy, CEO of the Medicines for Malaria Venture and Harald Nusser, Head of Novartis Social Business
Article

Today is World Malaria Day, when the world’s attention turns to a mosquito-borne disease that infects millions of people in Africa, Asia-Pacific and Latin America each year.

Watch: Together We Can End Malaria for Good - New Videos from Novartis Mark World Malaria Day

The fight against malaria continues to advance, led by the hard work of countless people. On World Malaria Day, meet some of the faces behind the Novartis Malaria Initiative and listen to their stories.
Article

Novartis is proud of the passion of our people and their dedication to the fight against malaria.

Meet some of the faces behind the Novartis Malaria Initiative and listen to their stories in our new series of videos:

Watch the full video - Together we can end malaria for good

View indivdual stories:

The Specter of Malaria That Resists Treatment, New Photo Essay from Novartis

The fight against malaria continues to advance, led by the hard work of countless people in their communities. On World Malaria Day, a new photo essay from Novartis presents a collection of scenes on the ground.
Article

The fight against malaria continues to advance in Southeast Asia and Sub-Saharan Africa, led by the hard work of countless people like Agnes Akoth and Dismus Mwalukwanda, who head out every day to their communities with a firm belief that they can make a difference.

Sandoz Announces Winners of Inaugural Healthcare Access Challenge (Sandoz HACk)

Summary: 
  • Three winners, chosen by expert panel at Wired Health 2017 in London, identified innovative approaches to address access challenges in Ghana, the Maldives and the Philippines.
  • Winning ideas proposed novel ways to use mobile technologies to connect patients with caregivers and essential medicines.
  • Sandoz invited young people worldwide to “reimagine access to healthcare” – arguably the largest unmet medical need.
Press Release
  • Three winners, chosen by expert panel at Wired Health 2017 in London, identified innovative approaches to address access challenges in Ghana, the Maldives and the Philippines.
  • Winning ideas proposed novel ways to use mobile technologies to connect patients with caregivers and essential medicines.
  • Sandoz invited young people worldwide to “reimagine access to healthcare” – arguably the largest unmet medical need.

Broadband Commission Working Group: New Report on Digital Health Released

Despite its promise, digital health is yet to reach scale in many of the countries which need it most. A new report from the Novartis Foundation, Nokia and the Broadband Commission Working Group on Digital Health explores what it takes to change this.
Article

The potential for harnessing the exponential growth in information and communications technology (ICT) to meet health challenges is clear. Mobile is the fastest adopted technology of all time: in 1991, mobile cellular penetration stood at less than 1%, compared to 99.7% in 2016 – and there will be an estimated 5.6 billion smartphones by 2020. Around 90% of that growth will come from low- and middle-income countries (LMICs).

Novartis Foundation Dialogue Explores Urban Health Challenges in Africa

More than half the world’s population now lives in urban areas and healthcare services in growing cities are struggling. Experts from around the world are in Cape Town this week to discuss this growing health challenge.
Article

Rapid urbanization in low- and middle-income countries is having a significant impact on the health and wellbeing on the world’s population.  For the first time in history, more than 50% of the world’s population lives in an urban area – and by 2050, it’s estimated that 70% of will be living in towns and cities. Healthcare services in growing cities are struggling, and are already swamped with ongoing challenges like infectious diseases.

World Leprosy Day: 4 Stories That Show the Ongoing Impact of Leprosy

The Novartis Foundation shares four new Global Health Stories to highlight the impact of leprosy on patients, families and communities and our work to stop it.
Article

As part of the Novartis Foundation’s effort to document the impact of leprosy on patients, their families and communities – as well as our work to stop it – we have added four new entries to our visual story-telling platform, called Global Health Stories.

Novartis Releases 2016 Corporate Responsibility Performance Report

Article

Novartis has published its Corporate Responsibility (CR) Performance Report for 2016. This year’s report provides even more context on the company’s CR performance, as well as views and comments on trends and challenges within the healthcare industry. 

This is the fourth consecutive year Novartis has published an annual CR Performance Report. In 2016, we again structured our report in accordance with the Global Reporting Initiative’s (GRI) G4 guidelines, with disclosure at “comprehensive” level.

Pages

Subscribe to Novartis